Robot vs. manual: which tool best spots lung cancer?

NCT ID NCT06308120

Ongoing Diagnosis Sponsor: Intuitive Surgical Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a robotic bronchoscopy system (Ion) to a manual one (superDimension) for diagnosing lung nodules. About 354 adults with suspicious lung nodules will be randomly assigned to one of the two devices. The main goal is to see which device yields a correct diagnosis more often, with fewer complications like collapsed lungs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ion Endoluminal System (robotic bronchoscopy device)
What this could lead to: If successful, this could show that robotic bronchoscopy is more accurate and safer for diagnosing lung nodules, potentially becoming a new standard of care.
What could go wrong: This is a device comparison trial, not a treatment study. Even if one device is better, it may not improve patient outcomes or survival. Results may not apply to all nodule types or hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm pulmonary coin lesion

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER PULMONARY NODULE, SOLITARY

Contacts and locations

Locations

Shanghai Chest Hospital

Shanghai, Shanghai Municipality, China
West China Hospital

Chengdu, Sichuan, China
Zhongshan Hospital

Shanghai, Shanghai Municipality, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.